You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

renal call carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Delving Into Participation Trends in Renal Cell Carcinoma

Not yet recruiting
  • Renal Cell Carcinoma
    • San Francisco, California
      Power Life Sciences
    Oct 16, 2023

    Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Recruiting
    • Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jun 5, 2023

    Among Advanced Renal Cell Carcinoma Receiving Systemic

    Not yet recruiting
    • Carcinoma, Renal Cell
      • (no location specified)
      Sep 6, 2022

      Metastatic and/or Advanced Renal Cell Carcinoma, Treated With

      Completed
      Has Results
      • Carcinoma
      • Renal Cell
      • London, United Kingdom
        Pfizer UK
      Jan 9, 2023

      Learn About First and Later Lines of Medicines in Treating

      Completed
      • Metastatic Renal Cell Carcinoma
        • New York, New York
          Pfizer Headquarters
        May 12, 2023

        Moesin Expression in Clear Cell Renal Cell Carcinoma

        Completed
        • Renal Cell Carcinoma
        • Immunohistochemical detection of Moesin in Clear cell Renal Cell Carcinoma
        • (no location specified)
        Sep 20, 2023

        ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

        Not yet recruiting
        • ccRCC
        • +20 more
        • (no location specified)
        Jul 6, 2023

        Renal Cell Carcinoma Trial (Sunitinib)

        Not yet recruiting
        • Renal Cell Carcinoma
        • (no location specified)
        Sep 11, 2023

        Clear Cell Renal Cell Carcinoma Trial in Los Angeles (89Zr-DFO-girentuximab)

        Available
        • Clear Cell Renal Cell Carcinoma
        • 89Zr-DFO-girentuximab
        • Los Angeles, California
          UCLA
        Oct 12, 2023

        Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

        Not yet recruiting
        • Clear Cell Renal Cell Carcinoma
        • 68Ga-NY104 PET/CT
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        May 28, 2023

        Clear Cell Renal Cell Carcinoma, Suspected Recurrent Renal Clear Cell Carcinoma, Recurrent Renal Cell Cancer Trial

        Not yet recruiting
        • Clear Cell Renal Cell Carcinoma
        • +2 more
        • (no location specified)
        May 14, 2023

        Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

        Not yet recruiting
        • Clear Cell Renal Cell Carcinoma
        • 68Ga-NY104 PET/CT
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        May 18, 2023

        Metastatic Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

        Not yet recruiting
        • Metastatic Clear Cell Renal Cell Carcinoma
        • 68Ga-NY104 PET/CT
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        May 18, 2023

        Renal Cell Carcinoma, Nasopharyngeal Carcinoma, Non Hodgkin Lymphoma Trial in United States (PRO1160)

        Not yet recruiting
        • Renal Cell Carcinoma
        • +2 more
        • Detroit, Michigan
        • +4 more
        Jan 31, 2023

        go Back Into Records and Observe How People With Metastatic

        Not yet recruiting
        • Carcinoma, Renal Cell
        • Clear-cell Metastatic Renal Cell Carcinoma
        • Istanbul, Turkey
          Pfizer
        Feb 15, 2023

        Sutureless Zero Ischemia Laparoscopic Tumor Enucleation for T1

        Recruiting
        • Carcinoma, Renal Cell
        • Kidney Neoplasms
          • Yiwu, Zhejiang, China
            The Fourth Affiliated Hospital Zhejiang University School of Med
          Mar 27, 2023

          Advanced Renal Cell Carcinoma Trial in Beijing (ST-1898 tablets)

          Recruiting
          • Advanced Renal Cell Carcinoma
          • ST-1898 tablets
          • Beijing, Beijing, China
            Peking University Cancer Hospital & Institute
          Nov 6, 2023

          Clear Cell Renal Cell Carcinoma?Resistance to Immunotherapy Trial in Shanghai (AK104(anti-PD-1/CTLA-4 bi-specific antibody

          Recruiting
          • Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
          • AK104（anti-PD-1/CTLA-4 bi-specific antibody ，intravenously）,lenvatinib（ targeted VEGFR 1-3、FGFR、PDGFRα， small molecule TKI，orally
          • Shanghai, Shanghai, China
            Shanghai Renji Hospital
          Sep 12, 2023

          Axitinib Dose Reduction and Interruption for Adverse Event

          Completed
          • Renal Cell Carcinoma
          • New York, New York
            Pfizer
          Sep 15, 2022

          Renal Cell Carcinoma Trial in Tabriz (Sodium Pentaborate)

          Not yet recruiting
          • Renal Cell Carcinoma
          • Sodium Pentaborate
          • Tabriz, East Azarbayejan, Iran, Islamic Republic of
            Imam Reza hospital and Clinic of Salamat
          Mar 23, 2023

          Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Boston (Implantable Microdevice (IMD))

          Not yet recruiting
          • Renal Cell Carcinoma
          • +2 more
          • Implantable Microdevice (IMD)
          • Boston, Massachusetts
            Dana-Farber Cancer Institute
          Jan 17, 2023

          Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)

          Not yet recruiting
          • Papillary Renal Cell Carcinoma
          • (no location specified)
          Nov 24, 2023

          Renal Cell Carcinoma Trial in Birmingham (Pembrolizumab injection)

          Not yet recruiting
          • Renal Cell Carcinoma
          • Pembrolizumab injection
          • Birmingham, Alabama
            University of Alabama at Birmingham
          Aug 20, 2023

          Clinical Factors on Prognosis of Papillary Renal Cell Carcinoma

          Completed
          • Carcinoma, Renal Cell
          • We do not have any interventions. This study is based on obseravation.
          • (no location specified)
          Oct 27, 2023

          Renal Cell Carcinoma, First-line Treatment, Non Clear Cell Renal Cell Carcinoma Trial in Chengdu (AK104, Axitinib)

          Not yet recruiting
          • Renal Cell Carcinoma
          • +3 more
          • Chengdu, Sichuan, China
            West China Hospital
          Apr 10, 2023